Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e92c1785d28665e090495ad80291e55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67f9c00d4e25be8104c59c1d2a2edd2d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-18 |
filingDate |
2022-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e09cdc37344cfcb1084e6d0ffb7a06d8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07105d3f5a4b762999f362518bd66e83 |
publicationDate |
2022-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-115282337-A |
titleOfInvention |
A kind of polycaprolactone microsphere pre-dispersed composition and polycaprolactone injection gel prepared therefrom |
abstract |
The invention discloses a polycaprolactone microsphere pre-dispersed composition and a polycaprolactone injection gel prepared therefrom. In the polycaprolactone microsphere pre-dispersed composition, the polycaprolactone microspheres can continue to maintain a complete spherical shape, have a smooth surface, have good dispersibility, reduce the degradation speed, and reduce air bubbles during the mixing process, which is conducive to ensuring product quality. It is stable and reduces the occurrence of nodules and granulomas caused by uneven dispersion of microspheres after injection in vivo. The polycaprolactone injection gel prepared by using it has better application value. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-116617466-A |
priorityDate |
2022-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |